% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • deanoandagana deanoandagana Feb 25, 2008 5:25 PM Flag

    analysts are a joke

    "In October 2007, we downgraded Vertex shares to 'Neutral' based on our loss of conviction that telaprevir would retain its best-in-class profile following interim data for Schering-Plough's boceprevir," she wrote in a note to clients. But McMinn now feels that new boceprevir data to be presented in April is likely to give Vertex investors more comfort in telaprevir's competitive profile.

    Thats great isnt it, we were in the high 30's until that, then get hammered into the teens and now she changes her mind, but I bet we dont recover back into the 30's

    SortNewest  |  Oldest  |  Most Replied Expand all replies
96.56-0.53(-0.55%)9:41 AMEDT